Brian Daniel Webster, the President and Chief Executive Officer of Kestra Medical Technologies, recently sold shares of the company as part of a trading plan. This transaction, reported in the latest SEC filing, highlights the ongoing activity among executives in the medical technology sector.
Background
Kestra Medical Technologies, based in Kirkland, Washington, operates within the surgical and medical instruments and apparatus industry. The company is identified under the Central Index Key (CIK) number 0001877184. It has been active in filing various reports with the SEC, including recent transactions that indicate significant movements in executive shareholdings.
What the Filing Says
In the SEC filing dated October 22, 2026, Webster reported two transactions that occurred on October 20, 2026. The first involved the sale of 13,316 common shares at a weighted average price of $29.5172, while the second transaction involved the sale of 1,684 shares at a weighted average price of $29.8920. Following these transactions, Webster retains ownership of 445,215 shares of Kestra Medical Technologies.
Impact
This activity may influence investor perceptions regarding the company's performance and management's confidence in its future. As the surgical and medical instruments industry evolves, such executive share transactions can provide insights into the strategic direction of companies like Kestra. Other executives and shareholders may closely monitor these developments.
What's Next
The filing does not say what happens next.